Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy by modulating the MeCP2/NLGN1 pathway.

Hu B, Wang Y, Yang Y, Wei H, Yang J

Open source

DOI
10.1016/j.brainresbull.2026.112135
Published
2026 Sep 23
Container
Brain research bulletin
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.brainresbull.2026.112135,
  title = {Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy by modulating the MeCP2/NLGN1 pathway.},
  author = {Hu B and Wang Y and Yang Y and Wei H and Yang J},
  year = {2026},
  journal = {Brain research bulletin},
  doi = {10.1016/j.brainresbull.2026.112135},
  url = {https://doi.org/10.1016/j.brainresbull.2026.112135}
}

RIS

TY  - JOUR
TI  - Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy by modulating the MeCP2/NLGN1 pathway.
AU  - Hu B
AU  - Wang Y
AU  - Yang Y
AU  - Wei H
AU  - Yang J
PY  - 2026
JO  - Brain research bulletin
DO  - 10.1016/j.brainresbull.2026.112135
UR  - https://doi.org/10.1016/j.brainresbull.2026.112135
ER  - 

APA

B, H., Y, W., Y, Y., H, W., & J, Y. (2026). Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy by modulating the MeCP2/NLGN1 pathway.. Brain research bulletin. https://doi.org/10.1016/j.brainresbull.2026.112135

Source records